The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Co-amoxiclav 250mg/125mg Film-coated tablets

250 mg/125 milligram(s) Film-coated tablet

Brown & Burk IR LimitedPA23148/004/001

Main Information

Trade NameCo-amoxiclav 250mg/125mg Film-coated tablets
Active SubstancesAmoxicillin (in the form of amoxicillin trihydrate)
Clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1))
Strength250 mg/125 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderBrown & Burk IR Limited
Licence NumberPA23148/004/001

Group Information

ATC CodeJ01CR Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02 amoxicillin and enzyme inhibitor

Status

Authorised/WithdrawnAuthorised
Licence Issued09/03/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0037-074-003
Interchangeable List DocumentPDF of Interchangeable List
« Back